A Phase I Study of the Safety and Feasibility of Bortezomib in Combination With G-CSF for Stem Cell Mobilization in Patients With Multiple Myeloma
- Resource Type
- Article
- Source
- In
Clinical Lymphoma, Myeloma and Leukemia October 2019 19(10):e588-e593 - Subject
- Language
- ISSN
- 2152-2650